Stephane Nave
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia.
Journal: British journal of haematology
Published: January 29, 2021
Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man.
Journal: Scientific reports
Published: October 09, 2020
Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy.
Journal: Annals of clinical and translational neurology
Published: July 23, 2020
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
Journal: Clinical pharmacology and therapeutics
Published: June 24, 2019
Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
Journal: Journal of Alzheimer's disease : JAD
Published: May 28, 2017
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 24, 2017
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 01, 2016
Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty.
Journal: Frontiers in aging neuroscience
Published: December 10, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026